Ibuprofen Dosing for Pericarditis
The recommended dose of ibuprofen for pericarditis is 600 mg every 8 hours (range 1200-2400 mg/day) for several weeks to months, with gradual tapering by 200-400 mg every 1-2 weeks after symptoms resolve and C-reactive protein normalizes. 1
Dosing and Administration Algorithm
Initial Dosing:
- 600 mg every 8 hours (1800 mg/day) 1
- Ensure full 24-hour coverage with q8h dosing to maintain anti-inflammatory effect
- Continue at full dose until complete symptom resolution AND normalization of CRP
Treatment Duration:
- Continue for weeks to months depending on clinical response 1
- Monitor symptoms and CRP levels to guide duration
Tapering Protocol:
- Begin tapering only after complete symptom resolution and CRP normalization
- Decrease dose by 200-400 mg every 1-2 weeks 1
- Longer tapering periods may be necessary for difficult or resistant cases
Combination Therapy
Ibuprofen should be combined with colchicine for optimal outcomes:
- Colchicine dosing:
Adding colchicine significantly reduces recurrence rates from 37.5% to 16.7% 4 and improves symptom resolution at 72 hours 4.
Monitoring and Follow-up
- Assess response at 72 hours for initial symptom improvement
- Follow-up every 1-2 weeks initially to monitor:
- Symptom resolution
- CRP normalization
- ECG changes
- Presence of pericardial effusion 2
Alternative NSAIDs
If ibuprofen is not tolerated or contraindicated, consider:
Aspirin: 500-1000 mg every 6-8 hours (range 1.5-4 g/day) 1
- Preferred in post-cardiac procedure settings due to antiplatelet effects 2
Indomethacin: 25-50 mg every 8 hours 1
- Start at lower end of dosing range
- Titrate upward cautiously to avoid headache and dizziness
Important Considerations and Pitfalls
Premature discontinuation: A leading cause of recurrence; continue treatment until both symptoms and inflammatory markers normalize 2
Inadequate dosing: Full anti-inflammatory doses given every 8 hours are necessary until symptoms resolve 2
Corticosteroid use: Avoid as first-line therapy due to higher recurrence rates; reserve for specific indications (systemic inflammatory diseases, pregnancy) or NSAID contraindications 1
Risk of recurrence: 15-30% of patients with idiopathic pericarditis will develop recurrent disease without colchicine 1, 3
Gastrointestinal protection: Consider gastroprotection with proton pump inhibitors in high-risk patients (elderly, history of peptic ulcer disease, concomitant anticoagulation)
Exercise restriction: Advise patients to restrict physical activity until symptoms resolve and CRP normalizes 2
By following this evidence-based dosing regimen and monitoring protocol, most patients with pericarditis will experience symptom relief and reduced risk of recurrence.